The study of ANagliptin effects on Glucagon LEvels of type 2 DM patients using insulin / ANGLE study
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Anagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms ANGLE
- 04 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 09 Feb 2017 Status changed from not yet recruiting to recruiting.
- 17 Oct 2016 New trial record